<SEC-DOCUMENT>0001415889-25-016006.txt : 20250606
<SEC-HEADER>0001415889-25-016006.hdr.sgml : 20250606
<ACCEPTANCE-DATETIME>20250606165044
ACCESSION NUMBER:		0001415889-25-016006
CONFORMED SUBMISSION TYPE:	SCHEDULE 13D/A
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20250606
DATE AS OF CHANGE:		20250606

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Tyra Biosciences, Inc.
		CENTRAL INDEX KEY:			0001863127
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				831476348
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-92865
		FILM NUMBER:		251031796

	BUSINESS ADDRESS:	
		STREET 1:		2656 STATE STREET
		CITY:			CARLSBAD
		STATE:			CA
		ZIP:			92008
		BUSINESS PHONE:		(619) 728-4760

	MAIL ADDRESS:	
		STREET 1:		2656 STATE STREET
		CITY:			CARLSBAD
		STATE:			CA
		ZIP:			92008

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RA CAPITAL MANAGEMENT, L.P.
		CENTRAL INDEX KEY:			0001346824
		ORGANIZATION NAME:           	
		EIN:				830406777
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A

	BUSINESS ADDRESS:	
		STREET 1:		200 BERKELEY STREET, 18TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116
		BUSINESS PHONE:		617-778-2500

	MAIL ADDRESS:	
		STREET 1:		200 BERKELEY STREET, 18TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	RA CAPITAL MANAGEMENT, LLC
		DATE OF NAME CHANGE:	20051213
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13D/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13D" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13D/A</submissionType>
		<previousAccessionNumber>0001104659-21-119792</previousAccessionNumber>
	    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001346824</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>





    </filerInfo>
  </headerData>

  <formData>
    <coverPageHeader>
		<amendmentNo>5</amendmentNo>
	      <securitiesClassTitle>Common Stock, $0.0001 par value per share</securitiesClassTitle>
      <dateOfEvent>06/04/2025</dateOfEvent>
	  <previouslyFiledFlag>false</previouslyFiledFlag>
      <issuerInfo>
        <issuerCIK>0001863127</issuerCIK>
        <issuerCUSIP>90240B106</issuerCUSIP>
		<issuerName>TYRA BIOSCIENCES, INC.</issuerName>

        <address>
          <com:street1>2656 State Street</com:street1>
                    <com:city>Carlsbad</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>92008</com:zipCode>
        </address>
      </issuerInfo>

	  	  <authorizedPersons>

		<notificationInfo>
			<personName>Peter Kolchinsky</personName>
			<personPhoneNum>617.778.2500</personPhoneNum>
				<personAddress>
					<com:street1>RA Capital Management, L.P.</com:street1>
					<com:street2>200 Berkeley Street, 18th Floor</com:street2>					<com:city>Boston</com:city>
					<com:stateOrCountry>MA</com:stateOrCountry>
					<com:zipCode>02116</com:zipCode>
				</personAddress>
		</notificationInfo>
			</authorizedPersons>
	    </coverPageHeader>

	<reportingPersons>


			<reportingPersonInfo>
									<reportingPersonCIK>0001346824</reportingPersonCIK>

				<reportingPersonNoCIK>N</reportingPersonNoCIK>
				<reportingPersonName>RA Capital Management, L.P.</reportingPersonName>





				  				  <fundType>AF</fundType>




				<legalProceedings>N</legalProceedings>

								<citizenshipOrOrganization>DE</citizenshipOrOrganization>
												<soleVotingPower>0.00</soleVotingPower>
												<sharedVotingPower>11899788.00</sharedVotingPower>
												<soleDispositivePower>0.00</soleDispositivePower>

				<sharedDispositivePower>11899788.00</sharedDispositivePower>
												<aggregateAmountOwned>11899788.00</aggregateAmountOwned>

				<isAggregateExcludeShares>N</isAggregateExcludeShares>

								<percentOfClass>22.4</percentOfClass>





			  			  <typeOfReportingPerson>IA</typeOfReportingPerson>

			  			  <typeOfReportingPerson>PN</typeOfReportingPerson>









			</reportingPersonInfo>

			<reportingPersonInfo>
									<reportingPersonCIK>0001384859</reportingPersonCIK>

				<reportingPersonNoCIK>N</reportingPersonNoCIK>
				<reportingPersonName>Peter Kolchinsky </reportingPersonName>





				  				  <fundType>AF</fundType>




				<legalProceedings>N</legalProceedings>

								<citizenshipOrOrganization>X1</citizenshipOrOrganization>
												<soleVotingPower>0.00</soleVotingPower>
												<sharedVotingPower>11899788.00</sharedVotingPower>
												<soleDispositivePower>0.00</soleDispositivePower>

				<sharedDispositivePower>11899788.00</sharedDispositivePower>
												<aggregateAmountOwned>11899788.00</aggregateAmountOwned>

				<isAggregateExcludeShares>N</isAggregateExcludeShares>

								<percentOfClass>22.4</percentOfClass>








			  			  <typeOfReportingPerson>HC</typeOfReportingPerson>



			  			  <typeOfReportingPerson>IN</typeOfReportingPerson>




			</reportingPersonInfo>

			<reportingPersonInfo>
									<reportingPersonCIK>0001619841</reportingPersonCIK>

				<reportingPersonNoCIK>N</reportingPersonNoCIK>
				<reportingPersonName>Rajeev Shah</reportingPersonName>





				  				  <fundType>AF</fundType>




				<legalProceedings>N</legalProceedings>

								<citizenshipOrOrganization>X1</citizenshipOrOrganization>
												<soleVotingPower>0.00</soleVotingPower>
												<sharedVotingPower>11899788.00</sharedVotingPower>
												<soleDispositivePower>0.00</soleDispositivePower>

				<sharedDispositivePower>11899788.00</sharedDispositivePower>
												<aggregateAmountOwned>11899788.00</aggregateAmountOwned>

				<isAggregateExcludeShares>N</isAggregateExcludeShares>

								<percentOfClass>22.4</percentOfClass>








			  			  <typeOfReportingPerson>HC</typeOfReportingPerson>



			  			  <typeOfReportingPerson>IN</typeOfReportingPerson>




			</reportingPersonInfo>

			<reportingPersonInfo>
									<reportingPersonCIK>0001315082</reportingPersonCIK>

				<reportingPersonNoCIK>N</reportingPersonNoCIK>
				<reportingPersonName>RA Capital Healthcare Fund, L.P.</reportingPersonName>






				  				  <fundType>WC</fundType>



				<legalProceedings>N</legalProceedings>

								<citizenshipOrOrganization>DE</citizenshipOrOrganization>
												<soleVotingPower>0.00</soleVotingPower>
												<sharedVotingPower>9909154.00</sharedVotingPower>
												<soleDispositivePower>0.00</soleDispositivePower>

				<sharedDispositivePower>9909154.00</sharedDispositivePower>
												<aggregateAmountOwned>9909154.00</aggregateAmountOwned>

				<isAggregateExcludeShares>N</isAggregateExcludeShares>

								<percentOfClass>18.6</percentOfClass>






			  			  <typeOfReportingPerson>PN</typeOfReportingPerson>









			</reportingPersonInfo>
			</reportingPersons>


	<items1To7>
		<item1>
			<securityTitle>Common Stock, $0.0001 par value per share</securityTitle>
			<issuerName>TYRA BIOSCIENCES, INC.</issuerName>

			<issuerPrincipalAddress>
			 <com:street1>2656 State Street</com:street1>
			  			  <com:city>Carlsbad</com:city>
			  <com:stateOrCountry>CA</com:stateOrCountry>
			  <com:zipCode>92008</com:zipCode>
			</issuerPrincipalAddress>

						<commentText>Item 1 of the Statement is amended and supplemented as follows:

This Amendment No. 5 (this "Amendment No. 5" or this "13D/A") amends and supplements the statement on Schedule 13D originally filed with the Securities and Exchange Commission (the "SEC") on September 27, 2021, and amended on February 6, 2024, October 22, 2024, November 13, 2024 and March 31, 2025 (as amended, the "Statement") by the Reporting Persons. Unless otherwise defined herein, capitalized terms used in this Amendment No. 5 shall have the meanings ascribed to them in the Statement. Unless amended or supplemented below, the information in the Statement remains unchanged.</commentText>
					</item1>

				<item2>
			<filingPersonName>This Amendment No. 5 is being filed on behalf of RA Capital Management, L.P. ("RA Capital"), Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P. (the "Fund"), who are collectively referred to herein as the "Reporting Persons."  The agreement among the Reporting Persons to file this 13D/A jointly in accordance with Rule 13d-1(k) of the Securities Exchange Act of 1934, as amended (the "Act"), is attached hereto as Exhibit 99.1.

The Reporting Persons' ownership of the Issuer's securities includes (i) 9,909,154 shares of Common Stock held directly by the Fund; (ii) 442,721 shares of Common Stock held by a separately managed account (the "Account"); (iii) 1,496,613 shares of Common Stock held by RA Capital Nexus Fund, L.P. (the "Nexus Fund"); (iv) Pre-Funded Warrants exercisable for up to 1,538,457 shares of Common Stock held directly by the Fund; (v) Exchange Warrants exercisable for up to 1,000,000 shares of Common Stock held directly by the Fund; (vi) a total of 47,600 shares underlying vested stock options (right to buy), and 3,700 shares underlying stock options (right to buy) which shall vest within 60 days of this filing held by Dr. Jake Simson for the benefit of RA Capital. The Pre-Funded Warrants and the Exchange Warrants each contain a provision (collectively the "Beneficial Ownership Blocker") which precludes exercise of the warrants to the extent that, following exercise, the Fund, together with its affiliates and other attribution parties, would own more than 19.99% of the Common Stock outstanding. The Fund is currently prohibited from exercising the Pre-Funded Warrants and/or the Exchange Warrants by virtue of the Beneficial Ownership Blocker.

RA Capital Healthcare Fund GP, LLC is the general partner of the Fund and RA Capital Nexus Fund GP, LLC is the general partner of the Nexus Fund. The general partner of RA Capital is RA Capital Management GP, LLC, of which Dr. Kolchinsky and Mr. Shah are the controlling persons. RA Capital serves as investment adviser for the Fund, the Account, and the Nexus Fund and may be deemed a beneficial owner, for purposes of Section 13(d) of the Act, of any securities of the Issuer held by the Fund, the Account, or the Nexus Fund. The Fund and the Nexus Fund have delegated to RA Capital the sole power to vote and the sole power to dispose of all securities held in the Fund's and the Nexus Fund's portfolio, including the shares of the Issuer's Common Stock reported herein. Because the Fund and the Nexus Fund have divested themselves of voting and investment power over the reported securities they hold and may not revoke that delegation on less than 61 days' notice, the Fund and the Nexus Fund disclaim beneficial ownership of the securities they hold for purposes of Section 13(d) of the Act and therefore disclaim any obligation to report ownership of the reported securities under Section 13(d) of the Act. As managers of RA Capital, Dr. Kolchinsky and Mr. Shah may be deemed beneficial owners, for purposes of Section 13(d) of the Act, of any securities of the Issuer beneficially owned by RA Capital. RA Capital, Dr. Kolchinsky, and Mr. Shah disclaim beneficial ownership of the securities reported in this Statement other than for the purpose of determining their obligations under Section 13(d) of the Act, and the filing of the Statement shall not be deemed an admission that either RA Capital, Dr. Kolchinsky or Mr. Shah is the beneficial owner of such securities for any other purpose.
 </filingPersonName>			<principalBusinessAddress>The address of the principal business office of each of the Reporting Persons is 200 Berkeley Street, 18th Floor, Boston, MA 02116.</principalBusinessAddress>			<principalJob>The Fund is a private investment vehicle. RA Capital provides investment management services to the Fund, the Account and the Nexus Fund. The principal occupation of Dr. Kolchinsky and Mr. Shah is investment management.</principalJob>			<hasBeenConvicted>During the last five years, none of the Reporting Persons has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).</hasBeenConvicted>			<convictionDescription>During the last five years, none of the Reporting Persons has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree of final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.</convictionDescription>			<citizenship>See Item 6 of the cover pages.</citizenship>		</item2>

				<item3>
			<fundsSource>Item 3 of the Statement is hereby amended and supplemented as follows:

On June 4, 2025, the Fund purchased 461,383 shares of common stock in open market transactions at prices ranging from $9.81 to $10.15 per share (a weighted-average price of $9.99 per share).

On June 5, 2025, the Fund purchased 213,334 shares of common stock in open market transactions at prices ranging from $9.48 to $10.18 per share (a weighted-average price of $10.04 per share).

The above purchases were for cash and were funded by the working capital of the Fund.

June 2025 Stock Purchase Agreement

On June 4, 2025, the Fund purchased 536,481 shares of common stock from Canaan XI L.P. in a privately negotiated transaction at a price per share of $9.32. The purchase was for cash and will be funded by the working capital of the Fund.</fundsSource>
		</item3>


				<item5>
			 <percentageOfClassSecurities>Rows 11 and 13 of each Reporting Person's cover page to this Schedule 13D set forth the aggregate number of shares of common stock and percentages of the shares of common stock beneficially owned by such Reporting Person and are incorporated by reference. The percentage set forth in each row 13 is based upon 53,177,990 shares of common stock outstanding as of May 6, 2025, as reported in the Issuer's Quarterly Report on Form 10-Q filed with the SEC on May 8, 2025, and giving effect to stock options, Pre-Funded Warrants and Exchange Warrants, to the extent exercisable within 60 days hereof, as referenced herein.
</percentageOfClassSecurities>			<numberOfShares>Rows 7 through 10 of each Reporting Person's cover page to this Schedule 13D/A set forth the number of shares of common stock as to which such Reporting Person has the sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition and are incorporated by reference.</numberOfShares>			<transactionDesc>Except as set forth herein, none of the Reporting Persons has effected any transactions with respect to the securities of the Issuer during the past sixty days:

													No.			Price Per
Transaction 					Purchaser	Date 		Shares 		Share

Vest Stock Option (Right to Buy) 	RA Capital	06/29/2025	       1,850 	(1)(2)
Vest Stock Option (Right to Buy) 	RA Capital	07/29/2025 	       1,850 	(1)(2)


(1) This option represents a right to purchase a total of 22,200 shares of the Issuer's common stock, which will begin vesting on June 29, 2025 in 12 equal monthly installments over one year, subject to Dr. Simson's continued service to the Issuer through each vesting date. These options have an exercise price of $9.25.

(2) Represents future vesting options within 60 days from the filing date of this Amendment No. 5.</transactionDesc>			<listOfShareholders>Except as set forth below, none of the Reporting Persons has effected any transactions with respect to the securities of the Issuer since the most recent amendment to this Schedule 13D/A.</listOfShareholders>			<date5PercentOwnership>Not applicable.</date5PercentOwnership>		</item5>


				<item7>
			<filedExhibits>Exhibit 99.1	Joint Filing Agreement
Exhibit 99.2	Stock Purchase Agreement</filedExhibits>
		</item7>

	</items1To7>

<signatureInfo>

	<signaturePerson>
		<signatureReportingPerson>RA Capital Management, L.P.</signatureReportingPerson>

					<signatureDetails>
				<signature>/s/ Peter Kolchinsky</signature>
				<title>By Peter Kolchinsky, Authorized Signatory</title>
				<date>06/06/2025</date>
			</signatureDetails>

	</signaturePerson>

	<signaturePerson>
		<signatureReportingPerson>Peter Kolchinsky </signatureReportingPerson>

					<signatureDetails>
				<signature>/s/ Peter Kolchinsky</signature>
				<title>Peter Kolchinsky</title>
				<date>06/06/2025</date>
			</signatureDetails>

	</signaturePerson>

	<signaturePerson>
		<signatureReportingPerson>Rajeev Shah</signatureReportingPerson>

					<signatureDetails>
				<signature>/s/ Rajeev Shah</signature>
				<title>Rajeev Shah</title>
				<date>06/06/2025</date>
			</signatureDetails>

	</signaturePerson>

	<signaturePerson>
		<signatureReportingPerson>RA Capital Healthcare Fund, L.P.</signatureReportingPerson>

					<signatureDetails>
				<signature>/s/ Peter Kolchinsky</signature>
				<title>By RA Capital Healthcare Fund GP, LLC, its General Partner, By Peter Kolchinsky, Manager</title>
				<date>06/06/2025</date>
			</signatureDetails>

	</signaturePerson>



</signatureInfo>
</formData>



</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex-99-06062025_080638.htm
<DESCRIPTION>JOINT FILING AGREEMENT
<TEXT>
<!DOCTYPE html PUBLIC "-//IETF//DTD HTML//EN">
<html><head><title>ex-99-06062025_080638.htm</title></head><body style="margin-top:0;font-family:Times New Roman; font-size:10pt; color:#000000">
<p style="margin:0px" align="right"><b>EXHIBIT 99.1</b></p>
<p style="margin:0px" align="right"><br></p>
<p style="margin:0px" align="center"><b>JOINT FILING AGREEMENT</b></p>
<p style="margin:0px"><br></p>
<p style="margin:0px" align="justify">This Joint Filing Agreement, dated as of June 6, 2025, is by and among RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the <font style="font-family:Arial Unicode MS,Times New Roman">&ldquo;</font>Filers<font style="font-family:Arial Unicode MS,Times New Roman">&rdquo;</font>). </p>
<p style="margin:0px" align="justify"><br></p>
<p style="margin:0px" align="justify">Each of the Filers may be required to file with the United States Securities and Exchange Commission a statement on Schedule 13G and/or 13D with respect to common stock, par value $0.0001 per share of Tyra Biosciences, Inc. beneficially owned by them from time to time.</p>
<p style="margin:0px" align="justify"><br></p>
<p style="margin:0px" align="justify">Pursuant to and in accordance with Rule 13(d)(1)(k) promulgated under the Securities Exchange Act of 1934, as amended, the Filers hereby agree to file a single statement on Schedule 13G and/or 13D (and any amendments thereto) on behalf of each of such parties, and hereby further agree to file this Joint Filing Agreement as an exhibit to such statement, as required by such rule.</p>
<p style="margin:0px" align="justify"><br></p>
<p style="margin:0px" align="justify">This Joint Filing Agreement may be terminated by any of the Filers upon one week<font style="font-family:Arial Unicode MS,Times New Roman">&rsquo;</font>s prior written notice or such lesser period of notice as the Filers may mutually agree.</p>
<p style="margin:0px"><br></p>
<p style="margin:0px">Executed and delivered as of the date first above written.</p>
<p style="margin:0px"><br></p>
<p style="margin:0px"><br></p>
<p style="margin:0px"><b>RA CAPITAL MANAGEMENT, L.P.</b></p>
<p style="margin:0px"><br></p>
<p style="margin-top:0px; margin-bottom:-2px; width:48px; float:left">By:</p>
<p style="margin:0px; text-indent:-2px"><u>/s/ Peter Kolchinsky</u></p>
<p style="margin-top:0px; margin-bottom:-2px; text-indent:48px; width:96px; clear:left; float:left">Name:</p>
<p style="margin:0px; padding-left:48px; text-indent:-2px">Peter Kolchinsky</p>
<p style="margin-top:0px; margin-bottom:-2px; text-indent:48px; width:96px; clear:left; float:left">Title:</p>
<p style="margin:0px; padding-left:48px; text-indent:-2px">Authorized Signatory</p>
<p style="margin:0px; clear:left"><br></p>
<p style="margin:0px"><br></p>
<p style="margin:0px"><b>PETER KOLCHINSKY</b></p>
<p style="margin:0px"><br></p>
<p style="margin:0px"><u>/s/ Peter Kolchinsky</u></p>
<p style="margin:0px"><br></p>
<p style="margin:0px"><br></p>
<p style="margin:0px"><b>RAJEEV SHAH</b></p>
<p style="margin:0px"><br></p>
<p style="margin:0px"><u>/s/ Rajeev Shah</u></p>
<p style="margin:0px"><br></p>
<p style="margin:0px"><br></p>
<p style="margin:0px"><b>RA CAPITAL HEALTHCARE FUND, L.P.</b></p>
<p style="margin:0px"><br></p>
<p style="margin-top:0px; margin-bottom:-2px; width:48px; float:left">By:</p>
<p style="margin:0px; text-indent:-2px">RA Capital Healthcare Fund GP, LLC</p>
<p style="margin-top:0px; margin-bottom:-2px; width:48px; clear:left; float:left">Its:</p>
<p style="margin:0px; text-indent:-2px">General Partner</p>
<p style="margin:0px; clear:left"><br></p>
<p style="margin-top:0px; margin-bottom:-2px; width:48px; float:left">By:</p>
<p style="margin:0px; text-indent:-2px"><u>/s/ Peter Kolchinsky</u></p>
<p style="margin-top:0px; margin-bottom:-2px; text-indent:48px; width:96px; clear:left; float:left">Name:</p>
<p style="margin:0px; padding-left:48px; text-indent:-2px">Peter Kolchinsky</p>
<p style="margin-top:0px; margin-bottom:-2px; text-indent:48px; width:96px; clear:left; float:left">Title:</p>
<p style="margin:0px; padding-left:48px; text-indent:-2px">Manager</p>
<p style="margin:0px; clear:left"><br></p>
<p style="margin:0px"><br></p>
<p style="margin-top:0px; margin-bottom:13.333px"><br></p>
<p style="margin-top:0px; margin-bottom:13.333px"><br></p>
</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>ex-99-06062025_080640.htm
<DESCRIPTION>STOCK PURCHASE AGREEMENT
<TEXT>
<!DOCTYPE html PUBLIC "-//IETF//DTD HTML//EN">
<html><head><title>ex-99-06062025_080640.htm</title></head><body style="margin-top:0;font-family:Times New Roman; font-size:10pt; color:#000000">
<p style="margin:0px"><br></p>
<p style="margin-top:0px; margin-bottom:16px; padding-left:384.067px; font-size:12pt" align="center"><b>STOCK PURCHASE AGREEMENT</b></p>
<p style="margin-top:0px; margin-bottom:16px; text-indent:47.933px; font-size:12pt" align="justify">This STOCK PURCHASE AGREEMENT (the <font style="font-family:Arial Unicode MS,Times New Roman">&ldquo;</font><u>Agreement</u><font style="font-family:Arial Unicode MS,Times New Roman">&rdquo;</font>) is made as of June 4, 2025 (the <font style="font-family:Arial Unicode MS,Times New Roman">&ldquo;</font><u>Effective Date</u><font style="font-family:Arial Unicode MS,Times New Roman">&rdquo;</font>), by and among RA Capital Healthcare Fund, L.P. a Delaware limited partnership (the <font style="font-family:Arial Unicode MS,Times New Roman">&ldquo;</font><u>Purchaser</u><font style="font-family:Arial Unicode MS,Times New Roman">&rdquo;</font>), on the one hand, and Canaan XI L.P., a limited partnership organized and existing under the laws of the Cayman Islands (<font style="font-family:Arial Unicode MS,Times New Roman">&ldquo;</font><u>Seller</u><font style="font-family:Arial Unicode MS,Times New Roman">&rdquo;</font>), on the other hand (each a <font style="font-family:Arial Unicode MS,Times New Roman">&ldquo;</font><u>Party</u><font style="font-family:Arial Unicode MS,Times New Roman">&rdquo;</font>).</p>
<p style="margin-top:0px; margin-bottom:16px; text-indent:47.933px; font-size:12pt" align="justify">The Seller desires to sell, and the Purchaser desires to buy, an aggregate of FIVE HUNDRED THIRTY-SIX THOUSAND FOUR HUNDRED EIGHTY-ONE (536,481) shares (the <font style="font-family:Arial Unicode MS,Times New Roman">&ldquo;</font><u>Shares</u><font style="font-family:Arial Unicode MS,Times New Roman">&rdquo;</font>) of the Common Stock, par value $0.0001 per share (the <font style="font-family:Arial Unicode MS,Times New Roman">&ldquo;</font><u>Common Stock</u><font style="font-family:Arial Unicode MS,Times New Roman">&rdquo;</font>), of Tyra Biosciences, Inc, a Delaware corporation (the <font style="font-family:Arial Unicode MS,Times New Roman">&ldquo;</font><u>Company</u><font style="font-family:Arial Unicode MS,Times New Roman">&rdquo;</font>), for a price per share of Nine Dollars and Thirty-Two Cents ($9.32) (<font style="font-family:Arial Unicode MS,Times New Roman">&ldquo;</font><u>Per Share Purchase Price</u><font style="font-family:Arial Unicode MS,Times New Roman">&rdquo;</font>) on the terms and conditions set forth in this Agreement. It is the intention of the parties to this Agreement that the transaction contemplated by this Agreement (the <font style="font-family:Arial Unicode MS,Times New Roman">&ldquo;</font><u>Transaction</u><font style="font-family:Arial Unicode MS,Times New Roman">&rdquo;</font>) be a private sale of securities that is exempt from the registration and prospectus delivery requirements of the Securities Act of 1933, as amended (the <font style="font-family:Arial Unicode MS,Times New Roman">&ldquo;</font><u>Securities Act</u><font style="font-family:Arial Unicode MS,Times New Roman">&rdquo;</font>), pursuant to Section 4(a)(7) of the Securities Act and pursuant to the satisfaction of the conditions for the so-called <font style="font-family:Arial Unicode MS,Times New Roman">&ldquo;</font>Section 4 (1 &frac12;)<font style="font-family:Arial Unicode MS,Times New Roman">&rdquo;</font> private resale exemption.</p>
<p style="margin-top:0px; margin-bottom:16px; text-indent:47.933px; font-size:12pt" align="justify">In consideration of the mutual covenants and agreements set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:</p>
<p style="margin-top:0px; margin-bottom:16px; padding-left:384.067px; font-size:12pt" align="center"><b>ARTICLE I</b></p>
<p style="margin-top:0px; margin-bottom:17.467px; font-size:12pt" align="center"><b>PURCHASE AND SALE OF THE SHARES</b></p>
<p style="margin-top:0px; margin-bottom:16px; text-indent:47.933px; font-size:12pt" align="justify">Section 1.1 <u>Purchase and Sale of Shares</u>. Subject to and in reliance upon the representations, warranties, terms and conditions of this Agreement, the Seller hereby agrees to sell, transfer and assign all of Seller<font style="font-family:Arial Unicode MS,Times New Roman">&rsquo;</font>s right, title and interest in and to the Shares to the Purchaser, and the Purchaser hereby agrees to purchase the Shares from the Seller at a price per Share equal to the Per Share Purchase Price, for an aggregate purchase price of F I V E M I L L I O N A N D T W O &nbsp;D O L L A R S &nbsp;A N D &nbsp;N I N E T Y - T W O &nbsp;C E N T S &nbsp;($5,000,002.92) (the <font style="font-family:Arial Unicode MS,Times New Roman">&ldquo;</font><u>Purchase Price</u><font style="font-family:Arial Unicode MS,Times New Roman">&rdquo;</font>).</p>
<p style="margin-top:0px; margin-bottom:16px; text-indent:47.933px; font-size:12pt" align="justify">Section 1.2 &nbsp;<u>The Closing</u>. The closing of the Transaction (the <font style="font-family:Arial Unicode MS,Times New Roman">&ldquo;</font><u>Closing</u><font style="font-family:Arial Unicode MS,Times New Roman">&rdquo;</font>) shall take place on the second business day after the Effective Date or such earlier time when the Closing conditions set forth in this Section 1.2 have been satisfied. At or prior to the Closing, the Seller shall, or shall cause its broker, UBS to, initiate the transfer of the Shares to the Purchaser and register the Shares in the Purchaser<font style="font-family:Arial Unicode MS,Times New Roman">&rsquo;</font>s name in book-entry form. At or prior to the Closing, the Purchaser shall deliver to the Seller the Purchase Price by wire transfer of immediately available funds to an account designated by Seller. Purchaser acknowledges that it may take several business days for Seller to complete the process of the transfer of the Shares to Purchaser via the Company<font style="font-family:Arial Unicode MS,Times New Roman">&rsquo;</font>s transfer agent.</p>
<p style="margin-top:0px; margin-bottom:-2px; text-indent:47.933px; width:144px; font-size:12pt; float:left">Section 1.3</p>
<p style="margin-top:0px; margin-bottom:16px; text-indent:-2px; font-size:12pt" align="justify"><u>Certain Definitions.</u></p>
<p style="margin-top:0px; margin-bottom:17.467px; padding-left:192px; text-indent:-48px; font-size:11pt; clear:left">(a)</p>
<p style="margin-top:0px; margin-bottom:17.467px"><br></p>
<div style="width:20.733px">
<p style="margin-top:0.667px; margin-bottom:0px; padding-left:4px; width:20.733px; font-size:12pt">1</p>
</div>
<p style="margin:0px"><br></p>
<hr style="margin-bottom: 9.6px; padding-top: 9.6px;" noshade size="1"><p style="margin:0px; page-break-before:always"><br></p>
<p style="margin-top:0px; margin-bottom:17.467px; padding-left:192px; text-indent:-48px; font-size:12pt"><font style="font-family:Arial Unicode MS,Times New Roman">&ldquo;</font><u>Action</u><font style="font-family:Arial Unicode MS,Times New Roman">&rdquo;</font> means any action, suit, proceeding, claim, arbitration, litigation or investigation, in each case by or before any Person.</p>
<p style="margin-top:0px; margin-bottom:-2px; text-indent:144px; width:192px; font-size:11pt; float:left">(b)</p>
<p style="margin-top:0px; margin-bottom:17.467px; padding-left:192px; text-indent:-2px; font-size:12pt"><font style="font-family:Arial Unicode MS,Times New Roman">&ldquo;</font><u>Affiliate</u><font style="font-family:Arial Unicode MS,Times New Roman">&rdquo;</font> means, with respect to any specified Person, any other Person that, directly or indirectly, through one or more intermediaries, controls, is controlled by or is under common control with, such specified Person.</p>
<p style="margin-top:0px; margin-bottom:-2px; text-indent:144px; width:192px; font-size:11pt; clear:left; float:left">(c)</p>
<p style="margin-top:0px; margin-bottom:17.467px; padding-left:192px; text-indent:-2px; font-size:12pt"><font style="font-family:Arial Unicode MS,Times New Roman">&ldquo;</font><u>Governmental Authority</u><font style="font-family:Arial Unicode MS,Times New Roman">&rdquo;</font> means any federal, state, local or foreign government or political subdivision thereof, or any agency or instrumentality of such government or political subdivision, or any self-regulated organization or other non-governmental regulatory authority or quasigovernmental authority (to the extent that the rules, regulations or orders of such organization or authority have the force of Law), or any arbitrator, court or tribunal of competent jurisdiction.</p>
<p style="margin-top:0px; margin-bottom:-2px; text-indent:144px; width:192px; font-size:11pt; clear:left; float:left">(d)</p>
<p style="margin-top:0px; margin-bottom:17.467px; padding-left:192px; text-indent:-2px; font-size:12pt"><font style="font-family:Arial Unicode MS,Times New Roman">&ldquo;</font><u>Law</u><font style="font-family:Arial Unicode MS,Times New Roman">&rdquo;</font> means any statute, law, ordinance, regulation, rule, code, order, constitution, treaty, common law, judgment, decree, other requirement or rule of law of any Governmental Authority.</p>
<p style="margin-top:0px; margin-bottom:-2px; text-indent:144px; width:192px; font-size:11pt; clear:left; float:left">(e)</p>
<p style="margin-top:0px; margin-bottom:17.467px; padding-left:192px; text-indent:-2px; font-size:12pt"><font style="font-family:Arial Unicode MS,Times New Roman">&ldquo;</font><u>Person</u><font style="font-family:Arial Unicode MS,Times New Roman">&rdquo;</font> means any individual, corporation, partnership, limited liability company, trust, unincorporated association, governmental entity or any agency, instrumentality or political subdivision of any governmental entity, or any other entity or body.</p>
<p style="margin-top:0px; margin-bottom:-2px; text-indent:144px; width:192px; font-size:11pt; clear:left; float:left">(f)</p>
<p style="margin-top:0px; margin-bottom:17.467px; padding-left:192px; text-indent:-2px; font-size:12pt"><font style="font-family:Arial Unicode MS,Times New Roman">&ldquo;</font><u>Representatives</u><font style="font-family:Arial Unicode MS,Times New Roman">&rdquo;</font> means, with respect to a Person, such Person<font style="font-family:Arial Unicode MS,Times New Roman">&rsquo;</font>s Affiliates, and the directors, officers, managers, stockholders, members, principals, partners, employees, agents, attorneys, accountants and other advisors and Representatives of such Person or any of its Affiliates.</p>
<p style="margin-top:0px; margin-bottom:16px; padding-left:384.067px; font-size:12pt; clear:left" align="center"><b>ARTICLE II</b></p>
<p style="margin-top:0px; margin-bottom:16px; padding-left:384.067px; font-size:12pt" align="center"><b>REPRESENTATIONS AND WARRANTIES OF SELLER</b></p>
<p style="margin-top:0px; margin-bottom:16px; text-indent:48px; font-size:12pt">The Seller hereby represents and warrants to the Purchaser as follows:</p>
<p style="margin-top:0px; margin-bottom:-2px; text-indent:47.933px; width:144px; font-size:12pt; float:left">Section 2.1</p>
<p style="margin-top:0px; margin-bottom:16px; text-indent:-2px; font-size:12pt" align="justify"><u>Authority and Approvals</u>. The Seller has the power and authority to enter into and perform its obligations under this Agreement, and all action necessary to authorize the execution, delivery and performance of this Agreement and the consummation of the Transaction has been duly and validly taken. The Agreement has been duly and validly executed and delivered by the Seller. Assuming this Agreement constitutes a valid and binding agreement of the Purchaser, this Agreement constitutes a valid and binding agreement of the Seller, enforceable against the Seller in accordance with its terms.</p>
<p style="margin-top:0px; margin-bottom:-2px; text-indent:47.933px; width:144px; font-size:12pt; clear:left; float:left">Section 2.2</p>
<p style="margin-top:0px; margin-bottom:16px; text-indent:-2px; font-size:12pt" align="justify"><u>The Shares</u>. The Seller<font style="font-family:Arial Unicode MS,Times New Roman">&rsquo;</font>s broker is the record owner of the Shares and the Seller is the beneficial owner of the Shares. Except for this Agreement, there is no agreement, arrangement or understanding with any other Person regarding the sale or transfer of any Shares, and there exist no liens, claims, options, proxies, voting agreements, charges or encumbrances of any kind affecting the Shares, other than any restrictions on transfer that may be imposed by Law. Upon transfer of the Shares to the Purchaser at the Closing against payment of the Purchase Price, the Purchaser will acquire ownership of the Shares, free and clear of all liens, </p>
<p style="margin-top:0px; margin-bottom:16px; clear:left" align="justify"><br></p>
<div style="width:20.733px">
<p style="margin-top:0.667px; margin-bottom:0px; padding-left:4px; width:20.733px; font-size:12pt">2</p>
</div>
<p style="margin:0px"><br></p>
<hr style="margin-bottom: 9.6px; padding-top: 9.6px;" noshade size="1"><p style="margin:0px; page-break-before:always"><br></p>
<p style="margin-top:0px; margin-bottom:16px; text-indent:47.933px; font-size:12pt" align="justify">claims, options, proxies, voting agreements, charges or encumbrances of any kind affecting the Shares, other than any restrictions on transfer that may be imposed by Law.</p>
<p style="margin-top:0px; margin-bottom:-2px; text-indent:47.933px; width:144px; font-size:12pt; float:left">Section 2.3</p>
<p style="margin-top:0px; margin-bottom:16px; text-indent:-2px; font-size:12pt" align="justify"><u>Investment Purpose; Affiliate Status; Holding Period</u>. The Seller represents that it (a) acquired the Shares for investment purposes only and not with a view toward distribution or resale in violation of any applicable securities Laws, (b) is selling the Shares, as principal, for its own account and not as a broker or agent for another party, (c) is not an <font style="font-family:Arial Unicode MS,Times New Roman">&ldquo;</font>affiliate<font style="font-family:Arial Unicode MS,Times New Roman">&rdquo;</font> of the Company as defined in Rule 144(a)(i) under the Securities Act, (d) has beneficially owned the shares for a least one (1) year, and (e) acquired and fully paid for the Shares at least one (1) year ago calculated in accordance with Rule 144(d) under the Securities Act.</p>
<p style="margin-top:0px; margin-bottom:-2px; text-indent:47.933px; width:144px; font-size:12pt; clear:left; float:left">Section 2.4</p>
<p style="margin-top:0px; margin-bottom:16px; text-indent:-2px; font-size:12pt" align="justify"><u>No General Solicitation; etc</u>. The Seller acknowledges that (a) neither the Purchaser nor any of its Representatives has either directly or indirectly, including through a broker or finder engaged in any general solicitation relating to the purchase of the Shares; and (b) the Purchase Price was determined through private arm<font style="font-family:Arial Unicode MS,Times New Roman">&rsquo;</font>s length negotiations between the Purchaser and the Seller, and neither the Purchaser nor the Seller is under any obligation or compulsion to enter into this Agreement.</p>
<p style="margin-top:0px; margin-bottom:-2px; text-indent:47.933px; width:144px; font-size:12pt; clear:left; float:left">Section 2.5</p>
<p style="margin-top:0px; margin-bottom:16px; text-indent:-2px; font-size:12pt" align="justify"><u>Conflicts</u>. The execution, delivery and performance of this Agreement will not (i) violate, conflict with, or result in the breach, acceleration, default or termination of, or otherwise give any other contracting party the right to terminate, accelerate, modify or cancel any of the terms, provisions, or conditions of the organizational documents of the Seller or any material agreements or instrument to which the Seller is a party or by which it or its assets may be bound, or (ii) constitute a violation of any material applicable Law.</p>
<p style="margin-top:0px; margin-bottom:-2px; text-indent:47.933px; width:144px; font-size:12pt; clear:left; float:left">Section 2.6</p>
<p style="margin-top:0px; margin-bottom:16px; text-indent:-2px; font-size:12pt" align="justify"><u>Broker<font style="font-family:Arial Unicode MS,Times New Roman">&rsquo;</font>s Fees</u>. The Seller has no liability or obligation to pay any fees or commissions to any broker, finder or agent with respect to the Transaction.</p>
<p style="margin-top:0px; margin-bottom:-2px; text-indent:47.933px; width:144px; font-size:12pt; clear:left; float:left">Section 2.7</p>
<p style="margin-top:0px; margin-bottom:16px; text-indent:-2px; font-size:12pt" align="justify"><u>No Bad Actors</u>. Neither the Seller nor, to Seller<font style="font-family:Arial Unicode MS,Times New Roman">&rsquo;</font>s knowledge, any person that has been or will be paid (directly or indirectly) remuneration or a commission for such person<font style="font-family:Arial Unicode MS,Times New Roman">&rsquo;</font>s participation in the offer or sale of the Shares, including solicitation of purchasers for the Seller, is subject to an event that would disqualify an issuer or other covered person under Rule 506(d)(1) of Regulation D or is subject to a statutory disqualification described under Section 3(a)(39) of the Securities Exchange Act of 1934, as amended (the <font style="font-family:Arial Unicode MS,Times New Roman">&ldquo;</font><u>Exchange Act</u><font style="font-family:Arial Unicode MS,Times New Roman">&rdquo;</font>).</p>
<p style="margin-top:0px; margin-bottom:-2px; text-indent:47.933px; width:144px; font-size:12pt; clear:left; float:left">Section 2.8</p>
<p style="margin-top:0px; margin-bottom:16px; text-indent:-2px; font-size:12pt" align="justify"><u>Excluded Information.</u></p>
<p style="margin-top:0px; margin-bottom:-2px; text-indent:144px; width:192px; font-size:11pt; clear:left; float:left">(a)</p>
<p style="margin-top:0px; margin-bottom:17.467px; padding-left:192px; text-indent:-2px; font-size:12pt">The Seller acknowledges that the Purchaser is an existing stockholder of the Company and that the Purchaser may have access to and may possess nonpublic information regarding the Company not known to the other Party (the <font style="font-family:Arial Unicode MS,Times New Roman">&ldquo;</font><u>Excluded Information</u><font style="font-family:Arial Unicode MS,Times New Roman">&rdquo;</font>). The Excluded Information may or may not be material, may or may not have been publicly disclosed by or on behalf of the Company or the Purchaser, directly or indirectly, and may or may not be available to the Seller from sources other than the Company or the Purchaser. Such Excluded Information may include information received (A) by the Purchaser or its Representatives in their capacities as directors, stockholders or affiliates of the Company, (B) from the Company on a confidential basis, or (C) on a privileged basis from the attorneys, financial advisers or other Representatives of the Company. Although such Excluded Information may be indicative of a </p>
<p style="margin-top:0px; margin-bottom:17.467px; clear:left"><br></p>
<div style="width:20.733px">
<p style="margin-top:0.667px; margin-bottom:0px; padding-left:4px; width:20.733px; font-size:12pt">3</p>
</div>
<p style="margin:0px"><br></p>
<hr style="margin-bottom: 9.6px; padding-top: 9.6px;" noshade size="1"><p style="margin:0px; page-break-before:always"><br></p>
<p style="margin-top:0px; margin-bottom:17.467px; padding-left:192px; text-indent:-48px; font-size:12pt">value of the Shares that is substantially different than the Purchase Price, the Seller is experienced, sophisticated and knowledgeable in trading securities of public and private companies and understands the disadvantages to which the Seller may be subject on account of the disparity of information as between the Purchaser and the Seller, and the Seller has nonetheless deemed it appropriate to engage in the sale of the Shares hereunder. In respect of this Section 2.8, the Seller further represents, warrants and acknowledges that it: (a) is a sophisticated seller with respect to its Shares, (b) has adequate information concerning its Shares, (c) has conducted, to the extent it deemed necessary, an independent investigation of such matters as, in its judgment, is necessary for it to make an informed investment decision with respect to the sale of its Shares to the Purchaser and with respect to the Purchaser as the buyer of its Shares, and (d) has not relied upon the Purchaser for any investigation into, assessment of, or evaluation with respect to the sale of its Shares to the Purchaser or with respect to the Purchaser as the purchaser of the Shares.</p>
<p style="margin-top:0px; margin-bottom:-2px; text-indent:144px; width:192px; font-size:11pt; float:left">(b)</p>
<p style="margin-top:0px; margin-bottom:17.467px; padding-left:192px; text-indent:-2px; font-size:12pt">The Seller hereby:</p>
<p style="margin-top:0px; margin-bottom:-2px; text-indent:47.933px; width:144px; font-size:11pt; clear:left; float:left">(1)</p>
<p style="margin-top:0px; margin-bottom:17.467px; padding-left:144px; text-indent:-2px; font-size:12pt">agrees that neither the Purchaser nor its directors, officers, partners, stockholders, members, investors, employees, attorneys, agents or Representatives shall have any liability to the Seller or its affiliates with respect to the existence, possession or non-disclosure of any Excluded Information, whether arising directly or indirectly, primarily or secondarily, by contract or operation of law or otherwise, including as a matter of contribution, indemnification, set-off, rescission, or reimbursement;</p>
<p style="margin-top:0px; margin-bottom:-2px; text-indent:47.933px; width:144px; font-size:11pt; clear:left; float:left">(2)</p>
<p style="margin-top:0px; margin-bottom:17.467px; padding-left:144px; text-indent:-2px; font-size:12pt">waives any right, claim or cause of action, at law or in equity, arising from or relating to, directly or indirectly, the existence, possession or non- disclosure of any Excluded Information, including without limitation pursuant to Sections 10(b) and 20A of the Exchange Act, or the rules and regulations promulgated by the Securities and Exchange Commission under the Exchange Act, and relinquishes all rights and remedies accorded by applicable law to a seller of securities with respect to the Shares to the maximum extent permitted by law, as well as all rights to participate in any claim, action or remedy others may now or hereafter have with respect to the foregoing; and</p>
<p style="margin-top:0px; margin-bottom:-2px; text-indent:47.933px; width:144px; font-size:11pt; clear:left; float:left">(3)</p>
<p style="margin-top:0px; margin-bottom:17.467px; padding-left:144px; text-indent:-2px; font-size:12pt">with respect to the disposition and sale of the Shares, releases and discharges the Purchaser and its directors, officers, partners, stockholders, members, investors, employees, attorneys, agents or Representatives and all successors and assigns thereto (each a <font style="font-family:Arial Unicode MS,Times New Roman">&ldquo;</font><u>Purchaser</u> <u>Released Party</u><font style="font-family:Arial Unicode MS,Times New Roman">&rdquo;</font>) of and from any and all suits, demands, obligations, liabilities, claims and causes of action, contingent or otherwise, of every kind and nature, at law and in equity, which the Seller and/or its affiliates, successors or assigns may have against any Purchaser Released Party, to the extent arising from or in connection with the existence, possession or non-disclosure of any Excluded Information whether asserted, unasserted, absolute, contingent, known or unknown.</p>
<p style="margin-top:0px; margin-bottom:-2px; text-indent:144px; width:192px; font-size:11pt; clear:left; float:left">(a)</p>
<p style="margin-top:0px; margin-bottom:17.467px; padding-left:192px; text-indent:-2px; font-size:12pt">The Seller hereby represents to each Purchaser Released Party that (i) it has not assigned any claim or possible claim against the Purchaser Released Parties, (ii) it fully intends to release all claims against the Purchaser Released Parties as set forth above, and (iii) it has been advised by, and has consulted with, counsel with respect to the execution and delivery of this Agreement and has been fully apprised of the consequences of the waivers and releases set forth in this Section 2.8.</p>
<p style="margin-top:0px; margin-bottom:16px; clear:left" align="center"><br></p>
<div style="width:20.733px">
<p style="margin-top:0.667px; margin-bottom:0px; padding-left:4px; width:20.733px; font-size:12pt">4</p>
</div>
<p style="margin:0px"><br></p>
<hr style="margin-bottom: 9.6px; padding-top: 9.6px;" noshade size="1"><p style="margin:0px; page-break-before:always"><br></p>
<p style="margin-top:0px; margin-bottom:16px; padding-left:384.067px; font-size:12pt" align="center"><b>ARTICLE III</b></p>
<p style="margin-top:0px; margin-bottom:17.467px; font-size:12pt" align="center"><b>REPRESENTATIONS AND WARRANTIES OF THE PURCHASER</b></p>
<p style="margin-top:0px; margin-bottom:16px; text-indent:48px; font-size:12pt">The Purchaser represents and warrants to the Seller as follows:</p>
<p style="margin-top:0px; margin-bottom:-2px; text-indent:47.933px; width:144px; font-size:12pt; float:left">Section 3.1</p>
<p style="margin-top:0px; margin-bottom:16px; text-indent:-2px; font-size:12pt" align="justify"><u>Authorization of Agreement</u>. The Purchaser has the power and authority to enter into and perform its obligations under this Agreement, and all action necessary on the part of the Purchaser to authorize the execution, delivery and performance of this Agreement and the consummation of the Transaction has been duly and validly taken. This Agreement has been duly and validly executed and delivered by the Purchaser. Assuming this Agreement constitutes a valid and binding obligation of the Seller, this Agreement constitutes a valid and binding agreement of the Purchaser, enforceable against the Purchaser in accordance with its terms.</p>
<p style="margin-top:0px; margin-bottom:-2px; text-indent:47.933px; width:144px; font-size:12pt; clear:left; float:left">Section 3.2</p>
<p style="margin-top:0px; margin-bottom:16px; text-indent:-2px; font-size:12pt" align="justify"><u>Conflicts</u>. The execution, delivery and performance of this Agreement will not (i) violate, conflict with, or result in the breach, acceleration, default or termination of, or otherwise give any other contracting party the right to terminate, accelerate, modify or cancel any of the terms, provisions, or conditions of the organizational documents of the Purchaser or any material agreements or instrument to which the Purchaser is a party or by which it or its assets may be bound, or (ii) constitute a violation of any material applicable Law.</p>
<p style="margin-top:0px; margin-bottom:-2px; text-indent:47.933px; width:144px; font-size:12pt; clear:left; float:left">Section 3.3</p>
<p style="margin-top:0px; margin-bottom:16px; text-indent:-2px; font-size:12pt" align="justify"><u>Investment Experience</u>. Purchaser is a sophisticated investor and has (a) by reason of its business and financial experience, the capacity to protect its own interests in connection with the purchase of the Shares hereunder, (b) such knowledge and experience in financial, tax and business matters to enable Purchaser to evaluate the merits and risks associated with the purchase of the Shares hereunder and to make an informed investment decision with respect thereto, (c) adequate information concerning the Shares, (d) conducted, to the extent it deemed necessary, an independent investigation of such matters as, in its judgment, is necessary for it to make an informed investment decision with respect to the Shares and the purchase of the Shares hereunder, and (e) not relied upon the Seller for any investigation into, assessment of, or evaluation with respect to the Shares and/or the purchase of the Shares hereunder. Without limiting the generality of the foregoing, the Purchaser has reviewed with its own tax advisors the federal, state, local and foreign tax consequences of its investment in the Shares and the Transaction. The Purchaser is relying solely on such advisors and not on any statements or representations of the Seller or any of its agents regarding the tax consequences of the Transaction. The Purchaser understands that it (and not the Seller) shall be responsible for the Purchaser<font style="font-family:Arial Unicode MS,Times New Roman">&rsquo;</font>s own tax liability that may arise as a result of its investment in the Shares and the Transaction.</p>
<p style="margin-top:0px; margin-bottom:-2px; text-indent:47.933px; width:144px; font-size:12pt; clear:left; float:left">Section 3.4</p>
<p style="margin-top:0px; margin-bottom:16px; text-indent:-2px; font-size:12pt" align="justify"><u>No General Solicitation, etc</u>. The Purchaser acknowledges that (a) neither the Seller nor any of its Representatives has either directly or indirectly, including through a broker or finder engaged in any general solicitation relating to the sale of the Shares; and (b) the Purchase Price was determined through private arm<font style="font-family:Arial Unicode MS,Times New Roman">&rsquo;</font>s length negotiations between the Purchaser and the Seller and neither the Purchaser nor the Seller is under any obligation or compulsion to enter into this Agreement.</p>
<p style="margin-top:0px; margin-bottom:16px; text-indent:47.933px; font-size:12pt; clear:left" align="justify">Section 3.5 &nbsp;<u>Opportunity to Seek Counsel</u>. The Purchaser has (a) had an opportunity to review and consider this Agreement before signing it, (b) consulted with its own attorney(s) and </p>
<p style="margin-top:0px; margin-bottom:16px" align="justify"><br></p>
<div style="width:20.733px">
<p style="margin-top:0.667px; margin-bottom:0px; padding-left:4px; width:20.733px; font-size:12pt">5</p>
</div>
<p style="margin:0px"><br></p>
<hr style="margin-bottom: 9.6px; padding-top: 9.6px;" noshade size="1"><p style="margin:0px; page-break-before:always"><br></p>
<p style="margin-top:0px; margin-bottom:16px; text-indent:47.933px; font-size:12pt" align="justify">confidential advisors before signing this Agreement, and (c) read and understood all of the terms and provisions of this Agreement.</p>
<p style="margin-top:0px; margin-bottom:-2px; text-indent:47.933px; width:144px; font-size:12pt; float:left">Section 3.6</p>
<p style="margin-top:0px; margin-bottom:16px; text-indent:-2px; font-size:12pt" align="justify"><u>No View to Distribution; Accredited Investor</u>. The Purchaser represents that it is buying the Shares (a) as principal, for its own accounts for investment only and not as a broker or agent for another party and (b) not with a view or any present intention toward effecting a distribution or resale in violation of any applicable securities laws. The Purchaser is an <font style="font-family:Arial Unicode MS,Times New Roman">&ldquo;</font>accredited investor<font style="font-family:Arial Unicode MS,Times New Roman">&rdquo;</font> as such term is defined in Regulation D of the Securities Act.</p>
<p style="margin-top:0px; margin-bottom:-2px; text-indent:47.933px; width:144px; font-size:12pt; clear:left; float:left">Section 3.7</p>
<p style="margin-top:0px; margin-bottom:16px; text-indent:-2px; font-size:12pt" align="justify"><u>Blue Sky Laws; Future Transfer</u>. The Purchaser acknowledges and agrees that the Shares have not been registered under the Securities Act or qualified under any state security laws (<font style="font-family:Arial Unicode MS,Times New Roman">&ldquo;</font><u>Blue Sky Laws</u><font style="font-family:Arial Unicode MS,Times New Roman">&rdquo;</font>) and may not be sold, pledged or otherwise transferred by the Purchaser without compliance with the registration provisions of the Securities Act or an exemption therefrom. The Purchaser acknowledges that the Shares are being transferred hereby under an exemption or exemptions from the registration and qualification requirements of the Securities Act and Blue Sky Laws which impose certain restrictions on the Purchaser<font style="font-family:Arial Unicode MS,Times New Roman">&rsquo;</font>s ability to transfer the Shares. The Purchaser is aware of the provisions of Rule 144 promulgated under the Securities Act, including without limitation the applicable holding periods thereunder.</p>
<p style="margin-top:0px; margin-bottom:-2px; text-indent:47.933px; width:144px; font-size:12pt; clear:left; float:left">Section 3.8</p>
<p style="margin-top:0px; margin-bottom:16px; text-indent:-2px; font-size:12pt" align="justify"><u>Broker<font style="font-family:Arial Unicode MS,Times New Roman">&rsquo;</font>s Fees</u>. The Purchaser has no liability or obligation to pay any fees or commissions to any broker, finder or agent with respect to the Transaction.</p>
<p style="margin-top:0px; margin-bottom:-2px; text-indent:47.933px; width:144px; font-size:12pt; clear:left; float:left">Section 3.9</p>
<p style="margin-top:0px; margin-bottom:16px; text-indent:-2px; font-size:12pt" align="justify"><u>Excluded Information.</u></p>
<p style="margin-top:0px; margin-bottom:-2px; text-indent:144px; width:192px; font-size:11pt; clear:left; float:left">(a)</p>
<p style="margin-top:0px; margin-bottom:17.467px; padding-left:192px; text-indent:-2px; font-size:12pt">Purchaser acknowledges and agrees that the Seller is an existing stockholder of the Company and that the Seller may have access to and may possess Excluded Information. The Excluded Information may or may not be material, may or may not have been publicly disclosed by or on behalf of the Company or the Seller, directly or indirectly, and may or may not be available to the Purchaser from sources other than the Company or the Seller. Such Excluded Information may include information received (A) by the Seller or its Representatives in their capacities as directors, officers, stockholders or affiliates of the Company, (B) from the Company on a confidential basis, or (C) on a privileged basis from the attorneys, financial advisers or other Representatives of the Company. Although such Excluded Information may be indicative of a value of the Shares that is substantially different than the Purchase Price, the Purchaser is experienced, sophisticated and knowledgeable in trading securities of public and private companies and understands the disadvantages to which the Purchaser may be subject on account of the disparity of information as between the Purchaser and the Seller, and the Purchaser has nonetheless deemed it appropriate to engage in the purchase of the Shares hereunder.</p>
<p style="margin-top:0px; margin-bottom:-2px; text-indent:144px; width:192px; font-size:11pt; clear:left; float:left">(b)</p>
<p style="margin-top:0px; margin-bottom:17.467px; padding-left:192px; text-indent:-2px; font-size:12pt">The Purchaser hereby: </p>
<p style="margin-top:0px; margin-bottom:-2px; text-indent:47.933px; width:144px; font-size:11pt; clear:left; float:left">(1)</p>
<p style="margin-top:0px; margin-bottom:17.467px; padding-left:144px; text-indent:-2px; font-size:12pt">agrees that neither the Seller nor its directors, officers, partners, stockholders, members, investors, employees, attorneys, agents or Representatives shall have any liability to the Purchaser or its affiliates with respect to the existence, possession or non-disclosure of any Excluded Information, whether arising directly or indirectly, primarily or secondarily, by contract or operation of law or otherwise, </p>
<p style="margin-top:0px; margin-bottom:17.467px; clear:left"><br></p>
<div style="width:20.733px">
<p style="margin-top:0.667px; margin-bottom:0px; padding-left:4px; width:20.733px; font-size:12pt">6</p>
</div>
<p style="margin:0px"><br></p>
<hr style="margin-bottom: 9.6px; padding-top: 9.6px;" noshade size="1"><p style="margin:0px; page-break-before:always"><br></p>
<p style="margin-top:0px; margin-bottom:17.467px; padding-left:144px; text-indent:-96.067px; font-size:12pt">including as a matter of contribution, indemnification, set-off, rescission, or reimbursement;</p>
<p style="margin-top:0px; margin-bottom:-2px; text-indent:47.933px; width:144px; font-size:11pt; float:left">(2)</p>
<p style="margin-top:0px; margin-bottom:17.467px; padding-left:144px; text-indent:-2px; font-size:12pt">waives any right, claim or cause of action, at law or in equity, arising from or relating to, directly or indirectly, the existence, possession or non- disclosure of any Excluded Information, including without limitation pursuant to Sections 10(b) and 20A of the Exchange Act, or the rules and regulations promulgated by the Securities and Exchange Commission under the Exchange Act, as well as all rights to participate in any claim, action or remedy others may now or hereafter have with respect to the foregoing; and</p>
<p style="margin-top:0px; margin-bottom:-2px; text-indent:47.933px; width:144px; font-size:11pt; clear:left; float:left">(3)</p>
<p style="margin-top:0px; margin-bottom:17.467px; padding-left:144px; text-indent:-2px; font-size:12pt">with respect to the disposition and sale of the Shares, releases and discharges the Seller and its directors, officers, partners, stockholders, members, investors, employees, attorneys, agents or Representatives and all successors and assigns thereto (each a <font style="font-family:Arial Unicode MS,Times New Roman">&ldquo;</font><u>Seller Released Party</u><font style="font-family:Arial Unicode MS,Times New Roman">&rdquo;</font>) of and from any and all suits, demands, obligations, liabilities, claims and causes of action, contingent or otherwise, of every kind and nature, at law and in equity, which the Purchaser and/or its affiliates, successors or assigns may have against any Seller Released Party, to the extent arising from or in connection with the existence, possession or non-disclosure of any Excluded Information whether asserted, unasserted, absolute, contingent, known or unknown.</p>
<p style="margin-top:0px; margin-bottom:-2px; text-indent:144px; width:192px; font-size:11pt; clear:left; float:left">(a)</p>
<p style="margin-top:0px; margin-bottom:17.467px; padding-left:192px; text-indent:-2px; font-size:12pt">The Purchaser hereby represents to each Seller Released Party that (i) it has not assigned any claim or possible claim against the Seller Released Parties, (ii) it fully intends to release all claims against the Seller Released Parties as set forth above, and (iii) it has been advised by, and has consulted with, counsel with respect to the execution and delivery of this Agreement and has been fully apprised of the consequences of the waivers and releases set forth in this Section 3.9.</p>
<p style="margin-top:0px; margin-bottom:16px; padding-left:384.067px; font-size:12pt; clear:left" align="center"><b>ARTICLE IV</b></p>
<p style="margin-top:0px; margin-bottom:16px; padding-left:384.067px; font-size:12pt" align="center"><b>MISCELLANEOUS</b></p>
<p style="margin-top:0px; margin-bottom:-2px; text-indent:47.933px; width:144px; font-size:12pt; float:left">Section 4.1</p>
<p style="margin-top:0px; margin-bottom:16px; text-indent:-2px; font-size:12pt" align="justify"><u>Legends</u>. The Purchaser understands that the Company may place restrictive legends on any stock certificate(s) or electronic book-entry evidencing the Shares as required by applicable law, the Company<font style="font-family:Arial Unicode MS,Times New Roman">&rsquo;</font>s governing documents or other policies.</p>
<p style="margin-top:0px; margin-bottom:-2px; text-indent:47.933px; width:144px; font-size:12pt; clear:left; float:left">Section 4.2</p>
<p style="margin-top:0px; margin-bottom:16px; text-indent:-2px; font-size:12pt" align="justify"><u>Expenses</u>. Each Party shall pay its own expenses incurred in connection with this Agreement, including, but not limited to, any fees payable to an agent, broker, investment or commercial banker, person or firm acting on behalf of or under the authority of such party who is entitled to any broker<font style="font-family:Arial Unicode MS,Times New Roman">&rsquo;</font>s or finder<font style="font-family:Arial Unicode MS,Times New Roman">&rsquo;</font>s fee or any other commission or fee directly or indirectly in connection with the Transaction. &nbsp;</p>
<p style="margin-top:0px; margin-bottom:-2px; text-indent:47.933px; width:144px; font-size:12pt; clear:left; float:left">Section 4.3</p>
<p style="margin-top:0px; margin-bottom:16px; text-indent:-2px; font-size:12pt" align="justify"><u>Severability</u>. If any provision of this Agreement shall be held invalid or unenforceable, each other provision hereof shall be given effect to the extent possible without such invalid or unenforceable provision and to that extent, the provisions of this Agreement shall be severable.</p>
<p style="margin-top:0px; margin-bottom:16px; clear:left" align="justify"><br></p>
<div style="width:20.733px">
<p style="margin-top:0.667px; margin-bottom:0px; padding-left:4px; width:20.733px; font-size:12pt">7</p>
</div>
<p style="margin:0px"><br></p>
<hr style="margin-bottom: 9.6px; padding-top: 9.6px;" noshade size="1"><p style="margin:0px; page-break-before:always"><br></p>
<p style="margin-top:0px; margin-bottom:-2px; text-indent:47.933px; width:144px; font-size:12pt; float:left">Section 4.4</p>
<p style="margin-top:0px; margin-bottom:16px; text-indent:-2px; font-size:12pt" align="justify"><u>Notices</u>. All notices, requests, demands and other communications hereunder shall be in writing and shall be delivered personally, mailed by certified or registered mail, postage prepaid, or sent by electronic mail, addressed to such address set forth on the signature page hereto. All such notices, requests, demands and other communications shall, when mailed (registered or certified mail, return receipt requested, postage prepaid), or personally delivered, be effective four days after deposit in the mails or when personally delivered, respectively, addressed as aforesaid, unless otherwise provided herein and, when sent by electronic mail during normal business hours of the recipient be effective when delivered, and if not sent during normal business hours, then on the recipient<font style="font-family:Arial Unicode MS,Times New Roman">&rsquo;</font>s next business day.</p>
<p style="margin-top:0px; margin-bottom:-2px; text-indent:47.933px; width:144px; font-size:12pt; clear:left; float:left">Section 4.5</p>
<p style="margin-top:0px; margin-bottom:16px; text-indent:-2px; font-size:12pt" align="justify"><u>Modifications, Consents and Waivers</u>. This Agreement may not be modified, amended, altered or supplemented except upon the execution and delivery of a written agreement executed by each of the parties hereto. Any Party may waive compliance, with respect to any obligations owed to such Party, with any provision of this Agreement. Any waiver hereunder shall be effective only if made in a writing signed by the Party to be charged therewith and only in the specific instance and for the purpose for which given. No failure or delay on the part of any Party in exercising any right, power, or privilege under this Agreement shall operate as a waiver thereof, nor shall any single or partial exercise of any right, power or privilege hereunder preclude any further exercise thereof or the exercise of any other right, power or privilege.</p>
<p style="margin-top:0px; margin-bottom:-2px; text-indent:47.933px; width:144px; font-size:12pt; clear:left; float:left">Section 4.6</p>
<p style="margin-top:0px; margin-bottom:16px; text-indent:-2px; font-size:12pt" align="justify"><u>Governing Law; Consent to Jurisdiction; Jury Waiver</u>. This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware (including its statutes of limitations), without giving effect to the principles of conflicts of laws thereof. Each Party irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the State of Delaware for the purposes of any Action (whether based on contract, tort or otherwise) directly or indirectly arising out of or in connection with this Agreement or the Transaction. Each Party agrees (a) to commence any such Action in such courts and (b) that service of any process, summons, notice or document by U.S. registered mail to such Party<font style="font-family:Arial Unicode MS,Times New Roman">&rsquo;</font>s respective address set forth on the signature page hereto shall be effective service of process with respect to any matters to which it has submitted to jurisdiction in this Section 4.6. Each Party irrevocably and unconditionally waives (i) any objection to the laying of venue of any such Action in such courts, or that any such Action brought in any such court has been brought in an inconvenient forum, and (ii) all right to trial by jury in any such Action.</p>
<p style="margin-top:0px; margin-bottom:-2px; text-indent:47.933px; width:144px; font-size:12pt; clear:left; float:left">Section 4.7</p>
<p style="margin-top:0px; margin-bottom:16px; text-indent:-2px; font-size:12pt" align="justify"><u>No Other Representations; No Liability</u>. Each Party acknowledges that the representations and warranties of the other Party expressly and specifically set forth herein constitute such other Party<font style="font-family:Arial Unicode MS,Times New Roman">&rsquo;</font>s sole and exclusive representations and warranties in connection with the Transaction, and further agrees that all other representations and warranties of any kind or nature express or implied are specifically disclaimed. Except for each Party<font style="font-family:Arial Unicode MS,Times New Roman">&rsquo;</font>s rights to enforce the terms of this Agreement, each Party hereby irrevocably waives and releases, to the fullest extent permitted by law, any and all Actions it has or may have against any other party, or any of its Representatives directly or indirectly based upon, relating to, or arising out of the Transaction, including any Action, whether under applicable securities Law or otherwise, directly or indirectly based upon, relating to, or arising out of the knowledge, possession, use or non- disclosure of any Excluded Information by such other Party or any of its Representatives.</p>
<p style="margin-top:0px; margin-bottom:16px; clear:left" align="justify"><br></p>
<div style="width:20.733px">
<p style="margin-top:0.667px; margin-bottom:0px; padding-left:4px; width:20.733px; font-size:12pt">8</p>
</div>
<p style="margin:0px"><br></p>
<hr style="margin-bottom: 9.6px; padding-top: 9.6px;" noshade size="1"><p style="margin:0px; page-break-before:always"><br></p>
<p style="margin-top:0px; margin-bottom:-2px; text-indent:47.933px; width:144px; font-size:12pt; float:left">Section 4.8</p>
<p style="margin-top:0px; margin-bottom:16px; text-indent:-2px; font-size:12pt" align="justify"><u>Execution in Counterparts; E-signatures</u>. This Agreement may be executed by the parties individually or in counterparts, each of which shall be an original and all of which taken together shall constitute one and the same agreement. A facsimile or pdf signature including any electronic signatures complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com shall be considered due execution and shall be binding upon the signatory thereto with the same force and effect as if the signature were an original, not a facsimile or pdf (or other electronic reproduction of a) signature.</p>
<p style="margin-top:0px; margin-bottom:-2px; text-indent:47.933px; width:144px; font-size:12pt; clear:left; float:left">Section 4.9</p>
<p style="margin-top:0px; margin-bottom:16px; text-indent:-2px; font-size:12pt" align="justify"><u>Headings</u>. Article and section headings used in this Agreement are for convenience only and shall not affect the interpretation or construction of any provision of this Agreement.</p>
<p style="margin-top:0px; margin-bottom:-2px; text-indent:47.933px; width:144px; font-size:12pt; clear:left; float:left">Section 4.10</p>
<p style="margin-top:0px; margin-bottom:16px; text-indent:-2px; font-size:12pt" align="justify"><u>Entire Agreement</u>. This Agreement and the Exhibits hereto contain the entire agreement and understanding of the parties hereto with respect to the subject matter hereof and supersede all prior agreements and understandings relating to such subject matter.</p>
<p style="margin-top:0px; margin-bottom:16px; clear:left"><br></p>
<p style="margin:0px; font-size:12pt" align="center">[remainder of page intentionally left blank]</p>
<p style="margin:0px"><br></p>
<p style="margin-top:0px; margin-bottom:16px"><br></p>
<div style="width:20.733px">
<p style="margin-top:0.667px; margin-bottom:0px; padding-left:4px; width:20.733px; font-size:12pt">9</p>
</div>
<p style="margin:0px"><br></p>
<hr style="margin-bottom: 9.6px; padding-top: 9.6px;" noshade size="1"><p style="margin:0px; page-break-before:always"><br></p>
<p style="margin-top:0px; margin-bottom:16px; text-indent:47.933px; font-size:12pt">IN WITNESS WHEREOF, the parties have caused this Stock Purchase Agreement to be executed as of the date first above written.</p>
<p style="margin-top:0px; margin-bottom:16px; padding-left:264px; font-size:12pt"><b>PURCHASER:</b></p>
<p style="line-height:13.7pt; margin-top:0px; margin-bottom:17.467px; padding-left:264px; font-size:12pt"><b>RA CAPITAL HEALTHCARE FUND, L.P.</b></p>
<p style="margin-top:0px; margin-bottom:16px; padding-left:264px; font-size:12pt">By: RA Capital Healthcare Fund GP, LLC Its: General Partner</p>
<p style="margin:0px"><br></p>
<p style="margin:0px; padding-left:264px; font-size:12pt">By: &nbsp;<u>/s/ Rajeev Shah</u></p>
<p style="margin:0px; padding-left:264px; font-size:12pt">Name: Rajeev Shah</p>
<p style="margin:0px; padding-left:264px; font-size:12pt">Title: &nbsp;Manager</p>
<p style="margin:0px"><br></p>
<p style="margin-top:0px; margin-bottom:-2px; text-indent:264px; width:390px; font-size:12pt; float:left">Address:</p>
<p style="margin:0px; padding-left:264px; text-indent:-2px; font-size:12pt">RA Capital Management, L.P.</p>
<p style="margin:0px; padding-left:264px; text-indent:126px; font-size:12pt; clear:left">200 Berkeley Street, 18<sup>th</sup> Floor</p>
<p style="margin:0px; padding-left:264px; text-indent:126px; font-size:12pt">Boston, MA 02116</p>
<p style="margin:0px; padding-left:264px; text-indent:126px; font-size:12pt">Attn: General Counsel</p>
<p style="margin:0px"><br></p>
<p style="margin-top:0px; margin-bottom:-2px; text-indent:264px; width:390px; font-size:12pt; float:left">Email: </p>
<p style="margin:0px; padding-left:264px; text-indent:-2px; font-size:12pt">legal@racap.com</p>
<p style="margin:0px; clear:left"><br></p>
<p style="margin-top:0px; margin-bottom:16px"><br></p>
<div style="width:20.733px">
<p style="margin-top:0.667px; margin-bottom:0px; padding-left:4px; width:20.733px; font-size:12pt">10</p>
</div>
<p style="margin:0px"><br></p>
<hr style="margin-bottom: 9.6px; padding-top: 9.6px;" noshade size="1"><p style="margin:0px; page-break-before:always"><br></p>
<p style="margin-top:0px; margin-bottom:16px; text-indent:47.933px; font-size:12pt">IN WITNESS WHEREOF, the parties have caused this Stock Purchase Agreement to be executed as of the date first above written.</p>
<p style="margin-top:0px; margin-bottom:16px; padding-left:264px; font-size:12pt"><b>SELLER:</b></p>
<p style="margin:0px; padding-left:264px; font-size:12pt">Canaan XI L.P.</p>
<p style="margin:0px; padding-left:264px; font-size:12pt">By: Canaan Partners XI LLC, its general partner</p>
<p style="margin:0px"><br></p>
<p style="margin:0px; padding-left:264px; font-size:12pt">/s/ John J. Pacifico</p>
<p style="margin:0px; padding-left:264px; font-size:12pt">John J. Pacifico, III, Manager</p>
<p style="margin:0px"><br></p>
<p style="margin-top:0px; margin-bottom:-2px; text-indent:264px; width:390px; font-size:12pt; float:left">Address:</p>
<p style="margin:0px; padding-left:264px; text-indent:-2px; font-size:12pt">700 Fairfield Avenue, Suite 1</p>
<p style="margin:0px; padding-left:264px; text-indent:126px; font-size:12pt; clear:left">Stamford, CT, 06902</p>
<p style="margin:0px"><br></p>
<p style="margin-top:0px; margin-bottom:-2px; text-indent:264px; width:390px; font-size:12pt; float:left">Email:</p>
<p style="margin:0px; padding-left:264px; text-indent:-2px; font-size:12pt">jpacifico@canaan.com</p>
<p style="margin:0px; clear:left"><br></p>
<div style="width:20.733px">
<p style="margin-top:0.667px; margin-bottom:0px; padding-left:4px; width:20.733px; font-size:12pt">11</p>
</div>
<p style="margin:0px"><br></p>
</body></html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
